Source: Annual Congress 2002 - Lung cancer: clinical characteristics and prognosis
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
T. Blankenburg, J. Haerting, H. Neef, P. Schmidt, W. Schuette (Halle, Germany). Tumor stage and survival critical comparison of survival data obtained from a field study with those from the literature. Eur Respir J 2002; 20: Suppl. 38, 1716

Member's Comments

No comment yet.

Related content which might interest you: Limited role of Ki-67 in lung carcinoid tumor patients predicting overall short-term survival,A single institution experience Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 The role of EGFR expression in the survival of patients with lung cancer: a systematic review of the literature with meta-analysis Source: Eur Respir J 2001; 18: Suppl. 33, 478s Year: 2001 TNM and survival in small cell lung cancer: results of a population-based study Source: Eur Respir J 2001; 18: Suppl. 33, 394s Year: 2001 Effect of primary cilium-associated genes expression on the survival of mesothelioma patients: In silico investigation of TCGA data. Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside Year: 2020 Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis Source: Eur Respir J 2001; 18: 705-719 Year: 2001 Late-breaking abstract: Is primary tumour standardized uptake value (SUV) an independent prognostic factor for non small cell lung cancer (NSCLC)? A meta-analysis based on individual data Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011 The role of angiogenesis, assessed by microvessel count (MVC), on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis Source: Eur Respir J 2002; 20: Suppl. 38, 3s Year: 2002 Progression-free survival with first line treatment as prognostic factor of treatment success in subsequent lines in lung adenocarcinoma patients – who´s the „good responder“? Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Lung cancer. Clinical characteristics and 10-year survival in 1856 resected patients. A population based study Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases Year: 2009 Gender and survival in lung cancer (LC): results of a healthcare study in WestGermany Source: Eur Respir J 2001; 18: Suppl. 33, 229s Year: 2001 Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2011; 39: 9-28 Year: 2012 Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2012; 39: 9-28 Year: 2012 Genomic signatures as predictors of progression free and overall survival Source: Annual Congress 2013 –Biological signatures in thoracic oncology Year: 2013 Lung cancer survival in the UK: are the results from the national lung cancer audit (LUCADA) dependent on completeness of case reporting? Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis Source: ERJ Open Res, 5 (4) 00179-2019; 10.1183/23120541.00179-2019 Year: 2019 Validation and comparison of several published prognostic systems for patients with small cell lung cancer Source: Eur Respir J 2011; 38: 657-663 Year: 2011 GAP scoring system in IPF patients treated with antifibrotics: prognostic performance and 1- to 3- years mortality: a retrospective study Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data Source: Eur Respir J 2015; 46: 1751-1761 Year: 2015 The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis Source: Eur Respir J 2002; 20: 975-981 Year: 2002 Survival outcomes of non small cell lung cancer (NSCLC) patients who are suitable for radical treatment at initial presentation Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011